BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 30932218)

  • 1. The effects of sustained virological response to direct-acting anti-viral therapy on the risk of extrahepatic manifestations of hepatitis C infection.
    El-Serag HB; Christie IC; Puenpatom A; Castillo D; Kanwal F; Kramer JR
    Aliment Pharmacol Ther; 2019 Jun; 49(11):1442-1447. PubMed ID: 30932218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of sustained virological response on the risk of extrahepatic manifestations of hepatitis C virus infection.
    Mahale P; Engels EA; Li R; Torres HA; Hwang LY; Brown EL; Kramer JR
    Gut; 2018 Mar; 67(3):553-561. PubMed ID: 28634198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis C virus and its cutaneous manifestations: treatment in the direct-acting antiviral era.
    Wiznia LE; Laird ME; Franks AG
    J Eur Acad Dermatol Venereol; 2017 Aug; 31(8):1260-1270. PubMed ID: 28252812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Skin diseases and hepatitis virus C infection].
    Poljacki M; Gajinov Z; Ivkov M; Matić M; Golusin Z
    Med Pregl; 2000; 53(3-4):141-5. PubMed ID: 10965678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of hepatitis C virus associated extrahepatic manifestations].
    Duclos-Vallée JC
    Gastroenterol Clin Biol; 2002 Apr; 26 Spec No 2():B76-81. PubMed ID: 12180311
    [No Abstract]   [Full Text] [Related]  

  • 6. Evolution of HCV associated porphyria cutanea tarda after HCV sustained virologic response by direct acting antivirals.
    García-Fraile LJ; García-Buey L; Alonso Cerezo C; Sanz Sanz J; de Los Santos Gil I
    Gastroenterol Hepatol; 2022 Apr; 45(4):249-255. PubMed ID: 34562521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Extrahepatic manifestations of hepatitis C virus].
    Cohen P
    Presse Med; 2000 Feb; 29(4):209-14. PubMed ID: 10705902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis C Treatment in Patients With Porphyria Cutanea Tarda.
    Singal AK; Venkata KVR; Jampana S; Islam FU; Anderson KE
    Am J Med Sci; 2017 Jun; 353(6):523-528. PubMed ID: 28641714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Extrahepatic manifestations of HCV infection].
    Husa P
    Vnitr Lek; 2016; 62(9 Suppl 2):18-22. PubMed ID: 27723989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Extrahepatic manifestations in hepatitis C. Are they overlooked?].
    Kristiansen MG; Florholmen J
    Tidsskr Nor Laegeforen; 2001 Feb; 121(4):446-9. PubMed ID: 11255860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Extrahepatic manifestations related to hepatitis C virus].
    Opolon P; Lunel F
    Pathol Biol (Paris); 1995 Oct; 43(8):709-15. PubMed ID: 8745593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dermatologic disorders associated with chronic hepatitis C: effect of interferon therapy.
    Berk DR; Mallory SB; Keeffe EB; Ahmed A
    Clin Gastroenterol Hepatol; 2007 Feb; 5(2):142-51. PubMed ID: 16919505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extrahepatic manifestations of Hepatitis C Virus infection: a general overview and guidelines for a clinical approach.
    Zignego AL; Ferri C; Pileri SA; Caini P; Bianchi FB;
    Dig Liver Dis; 2007 Jan; 39(1):2-17. PubMed ID: 16884964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Extrahepatic manifestation associated with HCV infection].
    Nagao Y; Sata M
    Nihon Shokakibyo Gakkai Zasshi; 1999 Nov; 96(11):1249-57. PubMed ID: 10586600
    [No Abstract]   [Full Text] [Related]  

  • 15. A Review on Extrahepatic Manifestations of Chronic Hepatitis C Virus Infection and the Impact of Direct-Acting Antiviral Therapy.
    Mazzaro C; Quartuccio L; Adinolfi LE; Roccatello D; Pozzato G; Nevola R; Tonizzo M; Gitto S; Andreone P; Gattei V
    Viruses; 2021 Nov; 13(11):. PubMed ID: 34835054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Skin manifestations related to hepatitis C viruses].
    Doutre MS; Beylot C; Beylot-Barry M; Couzigou P; Beylot J
    Rev Med Interne; 1995; 16(9):666-72. PubMed ID: 7481154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rheumatoid factor and immunoglobulin M mark hepatitis C-associated mixed cryoglobulinaemia: an 8-year prospective study.
    Cheng YT; Cheng JS; Lin CH; Chen TH; Lee KC; Chang ML
    Clin Microbiol Infect; 2020 Mar; 26(3):366-372. PubMed ID: 31229596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extrahepatic manifestations of hepatitis C.
    Palekar NA; Harrison SA
    South Med J; 2005 Oct; 98(10):1019-23. PubMed ID: 16295816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sustained virologic response to direct-acting antiviral agents predicts better outcomes in hepatitis C virus-infected patients: A retrospective study.
    Colussi G; Donnini D; Brizzi RF; Maier S; Valenti L; Catena C; Cavarape A; Sechi LA; Soardo G
    World J Gastroenterol; 2019 Oct; 25(40):6094-6106. PubMed ID: 31686765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dermatologic Manifestations of Chronic Hepatitis C Infection.
    Sayiner M; Golabi P; Farhat F; Younossi ZM
    Clin Liver Dis; 2017 Aug; 21(3):555-564. PubMed ID: 28689593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.